Institutional Ownership Acumen Pharmaceuticals, Inc. (ABOS)
This table provides information about the institutional ownership of Acumen Pharmaceuticals, Inc. (ABOS). We have compiled data on the 78 institutions that hold shares in the stock, with a total of 41.8 Million shares, which have been reported (via 13F filing form) to have a value of $75.3 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ra Capital Management, L.P.
Boston, MA |
Nov 14, 2024 Q3 2024 |
14,932,063
shares
|
$27.6 Million
0.52% of portfolio
|
Q2 2024
New holding
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 27, 2024 Q3 2024 |
3,549,069
shares
|
$6.57 Million
0.0% of portfolio
|
Q3 2024
Added 5.39%
|
|
|
Sands Capital Ventures, LLC
Arlington, VA |
Nov 13, 2024 Q3 2024 |
3,417,075
shares
|
$6.32 Million
4.37% of portfolio
|
Q3 2021
New holding
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
2,300,059
shares
|
$4.26 Million
0.19% of portfolio
|
Q4 2023
Reduced 18.22%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,158,661
shares
|
$3.99 Million
0.0% of portfolio
|
Q2 2024
Added 1037.95%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
1,934,039
shares
|
$3.58 Million
0.0% of portfolio
|
Q3 2024
Added 1.96%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
1,834,753
shares
|
$3.39 Million
0.0% of portfolio
|
Q3 2024
Reduced 6.11%
|
|
|
Knollwood Investment Advisory, LLC
Hunt Valley, MD |
Nov 14, 2024 Q3 2024 |
1,628,510
shares
|
$3.01 Million
0.43% of portfolio
|
Q3 2023
Reduced 2.98%
|
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
Nov 14, 2024 Q3 2024 |
939,603
shares
|
$1.74 Million
0.01% of portfolio
|
Q1 2024
Added 28.15%
|
|
|
Laurion Capital Management LP
New York, NY |
Nov 14, 2024 Q3 2024 |
867,046
shares
|
$1.6 Million
0.03% of portfolio
|
Q3 2024
Reduced 26.42%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
864,528
shares
|
$1.6 Million
0.0% of portfolio
|
Q3 2024
Added 6.45%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
849,619
shares
|
$1.57 Million
0.0% of portfolio
|
Q3 2024
Reduced 18.8%
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Nov 13, 2024 Q3 2024 |
636,000
shares
|
$1.18 Million
0.01% of portfolio
|
Q3 2024
Reduced 5.07%
|
|
|
Pathstone Holdings, LLC
Englewood, NJ |
Nov 07, 2024 Q3 2024 |
517,283
shares
|
$956,973
0.01% of portfolio
|
Q3 2024
Added 7.72%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
516,406
shares
|
$955,351
0.0% of portfolio
|
Q3 2024
Added 18.29%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
487,596
shares
|
$902,052
0.0% of portfolio
|
Q3 2024
Added 14.01%
|
|
|
Pathstone Family Office, LLC
Englewood, NJ |
Nov 08, 2023 Q3 2023 |
478,790
shares
|
$885,761
0.01% of portfolio
|
Q2 2023
Reduced 2.45%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
469,100
shares
|
$867,835
0.0% of portfolio
|
Q3 2024
Added 19.64%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
309,507
shares
|
$572,587
0.0% of portfolio
|
Q3 2024
Reduced 0.42%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
308,850
shares
|
$571,372
0.0% of portfolio
|
Q3 2024
Added 340.66%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
306,100
shares
|
$566,285
0.0% of portfolio
|
Q3 2024
Reduced 9.46%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2024 Q3 2024 |
266,435
shares
|
$492,904
0.12% of portfolio
|
Q1 2024
Reduced 15.49%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
239,200
shares
|
$442,520
0.0% of portfolio
|
Q3 2024
Added 172.41%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
145,861
shares
|
$269,842
0.0% of portfolio
|
Q3 2024
Added 185.71%
|
|
|
Td Asset Management Inc
|
Nov 01, 2024 Q3 2024 |
139,206
shares
|
$257,531
0.0% of portfolio
|
Q3 2024
Reduced 6.45%
|